MDM. A. Druzhilov

M. A. Druzhilov

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


M. A. Druzhilov has a total of 17 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Anticoagulant therapy for atrial fibrillation and high risk of thromboembolic events in certain Russian regions in 2023

    by M. A. Druzhilov, O. Yu. Druzhilova, T. Yu. Kuznetsova, D. V. Gavrilov, Т. Ю. Кузнецова

    Aim. To conduct a retrospective analysis of anticoagulation prescription rate, including direct oral anticoagulants (DOAC), to patients with atrial fibrillation and high risk of thromboembolic events (TEEs) in certain Russian regions as of December 31, 2023.Material and methods. The analyzed group of patients was formed based on the information contained in the Webiomed predictive analytics platform (OOO K-Sky, Petrozavodsk, Russia). The information was presented as the extracted depersonalized anonymized data from the electronic health records of patients aged ≥18 years, attached to medical facilities of 17 Russian subjects (n=107561, men 37,8%, mean age 74,5±8,5 years, mean CHA2DS2-VASc score of 3,6±1,2) extracted by the continuous sampling method.Results. Anticoagulation prescription rate in the group as a whole was 53,7%, while the DOAC share in its structure was 87,0%. Acetylsalicylic acid for TEE prevention was prescribed in 10,6% of cases. With an increase of non-gender-specific CHA2DS2-VASc score, the percentage of people receiving anticoagulation increased — from 49,7% with 2 points to 73,9% with 8 points. Anticoagulation was prescribed to patients aged ≥75 years significantly less often (49,1%, pConclusion. The results of retrospective analysis indicate improvement in anticoagulation prescription rate for atrial fibrillation and a high risk of TEEs in certain Russian regions. Compared to a similar study for 2016-2019, in 2023 this indicator increased from 34,8% to 53,7%. The share of DOACs in anticoagulant therapy structure also increased significantly — from 52,0% to 87,0%. At the same time, oral anticoagulation rate in this cohort of patients still does not meet the requirements of current clinical guidelines.


  • Open Access

    Anticoagulant and disease-modifying therapy for atrial fibrillation and heart failure in certain Russian regions in 2023

    by M. A. Druzhilov, O. Yu. Druzhilova, T. Yu. Kuznetsova, D. V. Gavrilov, Т. Ю. Кузнецова

    Aim. Retrospective analysis of the prescription rate of anticoagulant and disease-modifying therapy (DMT) to patients with atrial fibril­lation (AF) and heart failure (HF) in certain Russian regions as of Decem­ber 31, 2023.Material and methods. A group of patients with AF and HF (n=7901, men 51,1%, mean age 72,4±11,3 years, mean CHA2DS2-VASc (congestive heart failure, hypertension, age ≥75 years, diabetes mellitus, stroke, vascular disease, age 65 to 74 years, sex category) score 4,1±1,5) was formed based on data from the Webiomed pre­dictive analytics platform and presented by depersonalized formalized data extracted using continuous sampling from electronic health records of patients aged ≥18 years in 22 Russian regions.Results. The anticoagulation prescription rate in the whole sample was 77,8%, while the proportion of direct oral anticoagulants was 72,9%. With CHA2DS2-VASc score ≥2 in men and ≥3 in women, anticoagulant therapy was prescribed in 77,9%. Renin-angiotensin-aldosterone system blockers were prescribed in 84,0% (valsartan+sacubitril — in 10,3%), β-blockers — in 80,2%, mineralocorticoid receptor antagonists — in 60,4%, sodium-glucose cotransporter 2 inhibitors — in 13,9%. In the subgroup of individuals with reduced and mildly reduced left ventricular ejection fraction, 4-agent DMT was received by 17,4%, 3-agent — by 42,6% of patients.Conclusion. Despite the positive changes in anticoagulant prescription rate and related proportion of direct oral anticoagulants for AF and HF in certain Russian regions in 2023 compared to a similar analysis for 2019 (62,5 vs 51,2%), it can still be considered inconsistent with current clinical guidelines. With a high prescription rate of renin-angiotensin-aldosterone system blockers, β-blockers and mineralocorticoid receptor antagonists in patients with AF and HF, there is still a low proportion of people receiving 4-agent DMT.

  • Problematic points of anticoagulant therapy for atrial fibrillation in certain Russian regions in 2016- 2019: results of a retrospective big data analysis

    by M. A. Druzhilov, O. Yu. Druzhilova, Z. A. Ilchenko, P. I. Chalaya, T. Yu. Kuznetsova

    Aim. This retrospective analysis of anticoagulant therapy prescription rate in patients with atrial fibrillation (AF) aged ³18 years in certain Russian regions in 20162019 using artificial intelligence technologies. Material and methods. Anonymized data of patients with AF aged ³18 years (n=144431; men, 42,0%; mean age, 68,9±15,7 years; mean CHA 2 DS 2 -VASc score, 3,2±1,8) were extracted from the Webiomed predictive analytics service using continuous sampling from electronic health records in medical facilities of 6 Russian constituent entities (Republic of Bashkortostan, Republic of Buryatia, Republic of Karelia, Republic of Sakha (Yakutia), Perm Krai, Yamalo-Nenets Autonomous Okrug) for 2016-2019 using artificial intelligence technologies. Results. Anticoagulant therapy prescription rate in the total sample was 29,7%. Patients with AF and a high thromboembolism risk received anticoagulants in 34,8% of cases. Anticoagulant therapy was prescribed significantly less frequently to women with AF compared to men. In the subgroup of individuals aged under 75 years, anticoagulant therapy prescription rate with a high thromboembolism risk exceeded the same indicator in the subgroup of individuals aged ³75 years as follows: 41,2% vs 29,6% (p2 DS 2 -VASc scale in the range from 33,2% to 61,9%, in patients aged ³75 years — in the range from 13,0% to 55,5%. We revealed that 23317 (16,1%) patients were prescribed direct oral anticoagulants, of which 9,655 (41,4%) patients initially received warfarin. Conclusion. The study results indicate an unsatisfactory anticoagulant therapy prescription rate in patients with AF and a high thromboembolism risk in certain Russian regions in 2016-2019. Despite its growth with a CHA 2 DS 2 -VASc score increase in the high-risk range, it did not comply with current clinical guidelines This specifies the need for stricter control over the implementation of treatment and diagnostic algorithms and local protocols for managing these patients.


  • Open Access

    Problematic points of anticoagulant therapy for atrial fibrillation in certain Russian regions in 2016- 2019: results of a retrospective big data analysis

    by M. A. Druzhilov, O. Yu. Druzhilova, Z. A. Ilchenko, P. I. Chalaya, T. Yu. Kuznetsova, Т. Ю. Кузнецова

    Aim. This retrospective analysis of anticoagulant therapy prescription rate in patients with atrial fibrillation (AF) aged ³18 years in certain Russian regions in 20162019 using artificial intelligence technologies.Material and methods. Anonymized data of patients with AF aged ³18 years (n=144431; men, 42,0%; mean age, 68,9±15,7 years; mean CHA2DS2-VASc score, 3,2±1,8) were extracted from the Webiomed predictive analytics service using continuous sampling from electronic health records in medical facilities of 6 Russian constituent entities (Republic of Bashkortostan, Republic of Buryatia, Republic of Karelia, Republic of Sakha (Yakutia), Perm Krai, Yamalo-Nenets Autonomous Okrug) for 2016-2019 using artificial intelligence technologies. Results. Anticoagulant therapy prescription rate in the total sample was 29,7%. Patients with AF and a high thromboembolism risk received anticoagulants in 34,8% of cases. Anticoagulant therapy was prescribed significantly less frequently to women with AF compared to men. In the subgroup of individuals aged under 75 years, anticoagulant therapy prescription rate with a high thromboembolism risk exceeded the same indicator in the subgroup of individuals aged ³75 years as follows: 41,2% vs 29,6% (p2DS2-VASc scale in the range from 33,2% to 61,9%, in patients aged ³75 years — in the range from 13,0% to 55,5%. We revealed that 23317 (16,1%) patients were prescribed direct oral anticoagulants, of which 9,655 (41,4%) patients initially received warfarin.Conclusion. The study results indicate an unsatisfactory anticoagulant therapy prescription rate in patients with AF and a high thromboembolism risk in certain Russian regions in 2016-2019. Despite its growth with a CHA2DS2-VASc score increase in the high-risk range, it did not comply with current clinical guidelines This specifies the need for stricter control over the implementation of treatment and diagnostic algorithms and local protocols for managing these patients.


  • Open Access

    Metabolic health of the population: a modern view of the problem and solutions

    by G. A. Chumakova, T. Yu. Kuznetsova, M. A. Druzhilov, O. V. Gritsenko, Т. Ю. Кузнецова

    Studying the metabolic health of population around the world is becoming a priority area of modern medicine. This is associated with an increase in the prevalence of overweight and obesity, which leads to a significant increase in related metabolic diseases, which are actually complications of obesity, primarily visceral. According to 2019 data, overweight and obesity are associated with 5 million deaths and 160 million disability-adjusted life years, more than half of which are due to cardiovascular diseases. This challenge requires the development of cardiometabolic medicine and the training of new specialists.


  • Open Access

    Patients with atrial fibrillation and a low risk of thromboembolic events: prescription rate of anticoagulant therapy according to a retrospective analysis

    by M. A. Druzhilov, T. Yu. Kuznetsova, Т. Ю. Кузнецова

    Aim. To conduct a retrospective analysis of the prevalence of main risk factors for thromboembolic events (TEEs) and the prescription rate of anticoagulant therapy (ACT) in patients with atrial fibrillation (AF) and a low CHA2DS2-VASc score in certain Russian regions using artificial intelligence technologies. Material and methods . The information was obtained from the Webiomed predictive analytics platform. The sample included 87601 patients with AF aged 18-74 years (men, 49,5%, mean age, 59,3±12,3 years, mean CHA 2 DS 2 -VASc score, 2,3±1,5) who received care in medical organizations in 6 constituent entities of the Russian Federation in the period from 2016 to 2019. CHA 2 DS 2 VASc score of 1 and 2 in a man and a woman, respectively, was regarded as a moderate risk, while score of 0 and 1, respectively, as a low risk of TEEs. Results. There were 22337 (25,5%) patients with AF at moderate risk and 18366 (21,0%) patients at low risk of TEEs. With a moderate risk of TEEs, CHA 2 DS 2 -VASc score of 1 in 70,4% of cases was determined by hypertension, while in 15,7% — by age 65-74 years, in 9,0% — by heart failure, in 2,9% — by myocardial infarction and/or peripheral arterial disease, in 2,0% — by type 2 diabetes. In patients with AF and a moderate risk of TEEs, ACT was prescribed in 4927 (22,1%) patients, while with a low risk of TEEs — in 1833 (10,0%). Among patients with AF and a high risk of TEEs (n=46898, 53,5%), 1216 (24,6%) patients with ischemic stroke (IS) did not initially have a high CHA 2 DS 2 -VASc risk. Conclusion. In clinical practice, among patients with AF aged 18-74 years, there are quite often individuals with CHA 2 DS 2 -VASc score of 1 not associated with sex. These patients need an individualized approach in ACT, which is the basis for prospective studies in order to optimize the assessment of cardioembolic IS risk, as well as to analyze the efficacy and safety of long-term ACT.


  • Open Access

    Atrial fibrillation in the elderly and long-livers: a retrospective analysis of the clinical profile of patients using artificial intelligence

    by M. A. Druzhilov, T. Yu. Kuznetsova, Т. Ю. Кузнецова

    Aim. Retrospective analysis of the clinical characteristics of elderly patients with atrial fibrillation (AF) and long-livers in individual subjects of the Russian Federation using artificial intelligence.Material and methods. The information was obtained from the Webiomed predictive analytics platform. The main database included 144431 patients with AF who received care in medical organizations in 6 constituent entities of the Russian Federation in the period 2016-2019. Of these, 56830 (39,3%) persons were aged ≥75 years: 47595 aged 75-89 years, 9235 aged ≥90 years.Results. Patients with AF aged ≥75 years compared with persons aged 18-74 years were characterized by a significantly higher incidence of hypertension, type 2 diabetes, estimated glomerular filtration rate 2, heart failure and peripheral atherosclerosis, thromboembolic (TEE), atherothrombotic and hemorrhagic events. The prescription rate of anticoagulant therapy (ACT) was 29,6% and was lower (pConclusion. The retrospective analysis indicates a high proportion of people aged ≥75 years in the structure of all patients with AF. This group is characterized by a significant comorbidity, a high TEE risk, hemorrhagic and atherothrombotic events. At the same time, the ACT prescription rate as of 2016-2019 in individual subjects of the Russian Federation did not meet the requirements of the clinical guidelines.


  • Open Access

    Atrial fibrillation and chronic kidney disease: main clinical characteristics of patients in selected subjects of the Russian Federation

    by M. A. Druzhilov, T. Yu. Kuznetsova, O. Yu. Druzhilova, U. D. Arustamova, D. V. Gavrilov, A. V. Gusev, Т. Ю. Кузнецова

    Aim. To compare clinical characteristics of patients with atrial fibrillation (AF) depending on renal filtration function based on a retrospective analysis of data in individual subjects of the Russian Federation (RF).Material and methods. The information was taken from the Webiomed predictive analytics platform, including 80775 patients with AF (men, 42,5%, mean age, 70,0±14,3 years) who underwent outpatient and/or inpatient treatment in medical organizations in 6 Russian subjects in 2016-2019 with data on blood creatinine levels. For comparative analysis, the ranges of estimated glomerular filtration rate (eGFR) were selected: ≥60 ml/min/1,73 m2, 30–59 ml/min/1,73 m2, and 2.Results. The analysis showed that 45128 (55,9%) patients were characterized by eGFR 2, of which in 35212 (78%) patients eGFR was in the range of 30-59 ml/min/1,73 m2, in 9916 (22%) — 2. Patients with eGFR 2 compared with those with eGFR ≥60 ml/min/1,73 m2 were older (75,4±10,9 vs 63,0±15,2 years, p2 in the age ranges ≤64 years and 65-74 years had a higher incidence of IS and MI compared with patients with eGFR ≥60 ml/min/173 m2. The frequency of ICH on warfarin compared with direct oral anticoagulants was significantly higher in the subgroup with eGFR of 30-59 ml/min/1,73 m2 (1,1 vs 0,7%, pConclusion. Patients with AF and eGFR 2 are charac­terized by greater comorbidity, a higher incidence of IS, MI and ICH compared with patients with AF and eGFR ≥60 ml/min/1,73 m2, while ACT prescription rate as of 2016-2019 in some Russian subjects was unsatisfactory. This emphasizes the need to optimize risk stratification, ACT and algorithms for the prevention of athero­thrombotic events, as well as the development of nephro­protective strategies to reduce the rate of progression of renal dys­function in this cohort of patients.


  • Open Access

    Clinical characteristics and frequency of anticoagulation in patients with atrial fibrillation and heart failure: results of a retrospective big data analysis

    by M. A. Druzhilov, T. Yu. Kuznetsova, D. V. Gavrilov, A. E. Andreichenko, R. E. Novitsky, Т. Ю. Кузнецова

    Aim. To evaluate the clinical characteristics and frequency of prescribed anticoagulant therapy for patients with atrial fibrillation (AF) and heart failure (HF) in subjects of the Russian Federation based on a retrospective big data analysis using artificial intelligence technologies.Material and methods. For retrospective analysis, information was obtained from the Webiomed predictive analytics platform, which includes depersonalized data from electronic health records of outand/ or inpatients in 6 subjects of the Russian Federation, extracted using artificial intelligence technologies. From the database of patients with AF (n=144431), a group of individuals (n=20970) with an established diagnosis of HF and information on left ventricular ejection fraction (LVEF) was selected.Results. Patients with AF and HF (men, 43,7%; age 72,1±13,2 years; LVEF, 58,9±11,0%) had a history of smoking in 36,6% of cases, hypertension — in 86,7%, type 2 diabetes — in 26,6%, gout — in 2,7%, stage III and IV-V chronic kidney disease — in 50,9 and 15,6%, lower limb peripheral arterial disease — in 15,8%. The incidence of ischemic stroke, LV myocardial infarction and pulmonary embolism was 8,8, 14,7 and 2,4%, respectively. Anticoagulants, including direct oral ones, were administered to patients with AF and HF in 62,5% and 32,0% of cases, respectively. The frequency of their appointment did not significantly differ depending on LVEF.Conclusion. Patients with AF and HF are characterized by significant comorbidity, a higher incidence of cardiovascular events compared with the group of individuals with AF without HF, and an unsatisfactory percentage of anticoagulant therapy.


  • Open Access

    Retrospective analysis of the prevalence of ischemic stroke and the appointment of anticoagulant therapy in patients with atrial fibrillation depending on the body mass index

    by M. A. Druzhilov, T. Yu. Kuznetsova, O. Yu. Druzhilova, M. K. Tsarkova, D. V. Gavrilov, A. V. Gusev, Т. Ю. Кузнецова

    Aim. To estimate the prevalence of ischemic stroke (IS) and the appointment of anticoagulant therapy in patients with atrial fibrillation (AF) depending on body mass index (BMI) as part of a retrospective analysis of big data from certain subjects of the Russian Federation using artificial intelligence technologies.Material and methods. The information was obtained from the Webiomed predictive analytics platform, which includes depersonalized data from electronic health records of patients in 6 Russian constituent, extracted using artificial intelligence technologies. Individuals with AF aged ≥18 years were selected with available data on BMI of 18,5-60,0 kg/m2 inclusive (n=56003; men, 41,0%; age, 67,4±14,5 years, CHA2DS2-VASc score, 3,4±1,8). The following BMI ranges were identified: 18,5-21,9 kg/m2, 22,0-24,9 kg/m2 (taken as a reference), 25,0-29,9 kg/m2, 30,0-34,9 kg/m2, 35,0-39,9 kg/m2 and 40,0-60,0 kg/m2. The indicators were analyzed in age ranges (≤64 years, 65-74 years, ≥75 years) separately among men and women.Results. Among men ≤64 years of age, patients with overweight and class 2 obesity were characterized by a significantly higher incidence of IS. Among women ≤64 years, a significantly higher frequency of IS was found in subgroups with overweight and class 1-3 obesity, while among women aged 65-74 years — in a subgroup with a BMI of 18,5-21,9 kg/m2. Patients aged ≥75 years showed an insignificant trend towards the maximum frequency of IS with a BMI of 18,5-21,9 kg/m2. A higher frequency of anticoagulant therapy prescription was found in subgroups with overweight and class 1-3 obesity; in most age and sex subgroups, the differences are significant. A significantly lower frequency of anticoagulant therapy prescription to persons ≥75 years of age with a BMI of 18,5-21,9 kg/m2 was noted.Conclusion. The study showed a significant BMI paradox in the context of the relationship between the frequency of IS and BMI value in patients with AF. A higher incidence of IS in persons ≤64 years of age with a BMI ≥25 kg/m2 compared with pa­tients with normal weight may be an additional argument for establishing an inde­pen­-dent prognostic role of obesity in the development of thromboembolic events in AF.